Literature DB >> 24393367

Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.

Li-Ping Chen1, Hai-Yang Dai, Zhuo-Zhi Dai, Chong-Tao Xu, Ren-Hua Wu.   

Abstract

AIM: We utilized single-voxel 1H magnetic resonance spectroscopy to determine biochemical abnormalities related to major depressive disorder (MDD) in the bilateral dorsolateral prefrontal cortex, anterior cingulate cortex (ACC), and cerebellar hemisphere before and after antidepressant treatment.
METHODS: Fifteen adult MDD patients and 15 age- and sex-matched healthy controls were involved. Magnetic resonance spectroscopy of the brain was conducted in all subjects at the beginning of the study and the depressed subjects were reassessed after 8 weeks of antidepressant treatment.
RESULTS: At baseline, N-acetyl aspartate (NAA), total glutamine plus glutamate (Glx) and myo-inositol (MI) levels in the bilateral ACC were significantly lower in MDD patients than in controls (P < 0.05/3). MI in the bilateral cerebellar hemisphere were also decreased in patients compared with controls. After the treatment, the lower NAA, Glx and MI in ACC were normalized in MDD patients and the NAA and Glx increased compared to baseline values. The MI levels in the bilateral cerebellar hemisphere were also normalized in patients. MI and choline levels in the right cerebellar hemisphere were elevated compared to those at baseline.
CONCLUSION: Our study suggests that metabolic abnormalities in the ACC and cerebellar hemisphere are implicated in MDD. Antidepressants may alter the local metabolic abnormalities in these areas.
© 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  N-acetyl aspartate; choline; glutamate/glutamine; myo-inositol; selective serotonin reuptake inhibitor

Mesh:

Substances:

Year:  2014        PMID: 24393367     DOI: 10.1111/pcn.12138

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  18 in total

1.  Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Florian Muellerklein; Malle Tagamets; Robert P McMahon; Frank Gaston; Peter Kochunov; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

Review 2.  Multimodal approaches to define network oscillations in depression.

Authors:  Otis Lkuwamy Smart; Vineet Ravi Tiruvadi; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2015-01-28       Impact factor: 13.382

Review 3.  Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review.

Authors:  Ilya Demchenko; Vanessa K Tassone; Sidney H Kennedy; Katharine Dunlop; Venkat Bhat
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

Review 4.  Glutamate Efflux across the Blood-Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System.

Authors:  Benjamin Fredrick Gruenbaum; Alexander Zlotnik; Amit Frenkel; Ilya Fleidervish; Matthew Boyko
Journal:  Metabolites       Date:  2022-05-20

5.  Variations in myo-inositol in fronto-limbic regions and clinical response to electroconvulsive therapy in major depression.

Authors:  Stephanie Njau; Shantanu H Joshi; Amber M Leaver; Megha Vasavada; Jessica Van Fleet; Randall Espinoza; Katherine L Narr
Journal:  J Psychiatr Res       Date:  2016-05-28       Impact factor: 4.791

6.  Neurometabolic characteristics in the anterior cingulate gyrus of Alzheimer's disease patients with depression: a (1)H magnetic resonance spectroscopy study.

Authors:  Zhongwei Guo; Jiangtao Zhang; Xiaozheng Liu; Hongtao Hou; Yulin Cao; Fuquan Wei; Japeng Li; Xingli Chen; Yuedi Shen; Wei Chen
Journal:  BMC Psychiatry       Date:  2015-12-02       Impact factor: 3.630

7.  Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 Tesla.

Authors:  Yan Li; Angela Jakary; Erin Gillung; Stuart Eisendrath; Sarah J Nelson; Pratik Mukherjee; Tracy Luks
Journal:  MAGMA       Date:  2016-02-09       Impact factor: 2.310

8.  Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T.

Authors:  Reggie Taylor; Elizabeth A Osuch; Betsy Schaefer; Nagalingam Rajakumar; Richard W J Neufeld; Jean Théberge; Peter C Williamson
Journal:  BJPsych Open       Date:  2017-02-02

Review 9.  Disentangling the Neural Basis of Cognitive Behavioral Therapy in Psychiatric Disorders: A Focus on Depression.

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  Brain Sci       Date:  2018-08-09

10.  Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T.

Authors:  Gwenn S Smith; Georg Oeltzschner; Neda F Gould; Jeannie-Marie S Leoutsakos; Najilla Nassery; Jin Hui Joo; Michael A Kraut; Richard A E Edden; Peter B Barker; S Andrea Wijtenburg; Laura M Rowland; Clifford I Workman
Journal:  J Affect Disord       Date:  2020-10-07       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.